Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4510 results

Sort By:

Digitally Prompted Parenting: A Text Message Parent-Based Alcohol Intervention for Incoming College Students

Study ID: NCT06861660
Start Date: 2025-07-01
End Date: 2026-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Digitally Prompted Parenting

Active Control

Sponsor

Loyola Marymount University

Source: clinicaltrials.gov

Share:
Add to list

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

Study ID: NCT06451757
Start Date: 2025-08-02
End Date: 2028-01-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

150

Intervention / Treatment

Sonlicromanol

Placebo

Sponsor

Khondrion BV

Source: clinicaltrials.gov

Share:
Add to list

PoCUS Impact on the Diagnostic Approach for Thoracic and Abdominal Pain in the ED

Study ID: NCT06827730
Start Date: 2025-06-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

406

Intervention / Treatment

Point of care ultrasound

Sponsor

Saint-Luc university clinics- Catholic University of Louvain

Source: clinicaltrials.gov

Share:
Add to list

Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK

Study ID: NCT06666348
Start Date: 2025-04-01
End Date: 2035-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Mirdamet

Sponsor

C17 Council

Source: clinicaltrials.gov

Share:
Add to list

A Combination of Rituximab and CC-99282 As Front-line Therapy for Older Frail Patients with Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated with a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)

Study ID: NCT06835530
Start Date: 2025-04
End Date: 2030-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

47

Intervention / Treatment

Rituximab + Golcadomide (CC-99282)

Sponsor

Italian Lymphomes Foundation - ETS

Source: clinicaltrials.gov

Share:
Add to list

ADHERE-LPV Advancing Delivery of High-Quality Evidence-Based Respiratory Efforts in Lung-Protective Ventilation

Study ID: NCT06895148
Start Date: 2025-04-16
End Date: 2026-07-16
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1125

Intervention / Treatment

New ventilator

control ventilator

Sponsor

The University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Innovative OSA Screening in Head and Neck Cancer Patients with the Apneal App

Study ID: NCT06896448
Start Date: 2025-04
End Date: 2026-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Specialized sleep consultation and overnight recording using the APNEAL application

Sponsor

University Hospital, Caen

Source: clinicaltrials.gov

Share:
Add to list

Medical Cannabis and Behavior

Study ID: NCT06808048
Start Date: 2025-04-15
End Date: 2029-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

Cognitive testing

Task-based fMRI measure of inhibitory control

Task-based fMRI measure of face-name learning

Sponsor

The University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Vaccine Pandemic Preparedness Through Airway Immunology Characterization

Study ID: NCT05921448
Start Date: 2025-08-01
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

60

Intervention / Treatment

Vauxigripra

Flumist

Sponsor

Chronic Obstructive Pulmonary Disease Trial Network, Denmark

Source: clinicaltrials.gov

Share:
Add to list

A Multicenter Phase II Clinical Study of Neoadjuvant Use of Camrelizumab in Combination with Chemotherapy for Organ Preservation in Esophageal Cancer

Study ID: NCT06869226
Start Date: 2025-04-30
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

283

Intervention / Treatment

Camrelizumab + Nab-paclitaxel + Cisplatin

Sponsor

Peking University Cancer Hospital & Institute

Source: clinicaltrials.gov

Share:
Add to list